Case Control Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 7, 2017; 23(21): 3864-3875
Published online Jun 7, 2017. doi: 10.3748/wjg.v23.i21.3864
Figure 2
Figure 2 Efficacy of studied miRNAs in hepatocellular carcinoma non-malignant differentiation using receiver operating characteristics curve analysis. Hepatocellular carcinoma (HCC) (n = 224) and healthy control (n = 84).